Vistin Pharma ASA (LON:0RAM)

London · Delayed Price · Currency is GBP · Price in NOK

21.50

+0.10 (0.47%)

At close: Mar 17, 2026

-10.04% (1Y)

Market Cap	74.34M -5.3%
Revenue (ttm)	33.34M +5.3%
Net Income	5.51M +19.1%
EPS	0.12 +19.1%
Shares Out	n/a
PE Ratio	13.49
Forward PE	n/a
Dividend	0.09 (0.42%)
Ex-Dividend Date	Jun 4, 2025

Volume	1,980
Average Volume	652
Open	21.50
Previous Close	21.40
Day's Range	21.50 - 21.50
52-Week Range	20.20 - 26.70
Beta	1.03
RSI	44.35
Earnings Date	Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1969

Employees 73

Stock Exchange London Stock Exchange

Ticker Symbol 0RAM

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.76 million, an increase of 19.13%.

Financial numbers in NOK Financial Statements